Ocrevus (Ocrelizumab Vials) 300mg / 10ml

Ocrelizumab is a prescription medication used to treat multiple sclerosis and other autoimmune conditions. This 300mg/10ml vial form is administered by healthcare professionals. Always consult a doctor before use. Short-term storage guidance may apply.

Strength

300mg / 10ml

Manufacturer / TM Owner

Roche Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ocrelizumab is primarily used to treat relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). It works by targeting specific immune cells to reduce inflammation and slow disease progression. Patients often ask, what is ocrelizumab used for, and it is prescribed for adults with active MS symptoms. The medication may also be used in other autoimmune conditions as determined by a healthcare provider.

Side Effects

After administration, ocrelizumab may lead to a reduction in MS relapses and slowed disability progression. Some patients report improved mobility and fewer flare-ups over time. Common effects include infusion-related reactions, which are typically managed under medical supervision. Individual responses vary, and regular monitoring is recommended.

Precautions & Warnings

Ocrelizumab should only be handled and administered by trained healthcare professionals. Patients with active infections or weakened immune systems may need careful evaluation before treatment. Regular blood tests and monitoring are often required to check for side effects. Always inform your doctor of any ongoing medical conditions or medications.

Avoid Interactions

Ocrelizumab may interact with other immunosuppressants or live vaccines, potentially increasing infection risk. Strong CYP450 enzyme inhibitors could affect its metabolism, though specific interactions vary. Alcohol and certain over-the-counter medications may also pose risks when combined. Always disclose all medications and supplements to your healthcare provider.

Frequently Asked Questions

Ocrelizumab is used to treat relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adults.

Ocrelizumab is given as an intravenous infusion by a healthcare professional, typically in a clinic or hospital setting.

Common effects include infusion-related reactions like fever or chills, and increased risk of infections due to its effect on the immune system.

Live vaccines are generally not recommended during or shortly after ocrelizumab treatment due to reduced immune response.

The dosing schedule varies by condition, but it is typically administered every 6 months after the initial doses.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.